Duchenne Muscular Dystrophy
description
Transcript of Duchenne Muscular Dystrophy
Duchenne Muscular DystrophyBecker Muscular Dystrophy
US Prevalence15,0002,200
Incidence Rate1/3,500 male birthsUnknown
InheritanceX-linkedX-linked
Gene locationXp21 (reading frame shifted)Xp21 (reading frame maintained)
ProteinDystrophinDystrophin
Onset2- 6 years4-12 years (severe EMD)Late teenage to adulthood (mild EMD)
Severity and courseRelentlessly progressiveReduced motor function by 2-3 yearsSteady decline in strengthLife span 16 years
WeaknessProximal > distalSymmetricLegs and armsProximal > distalSymmetricLegs and arms
CardiacDilated cardiomyopathy first to second decadeOnset of signs second decadeCardiomyopathy may occur before weakness, Third to fourth decade frequent
RespiratoryProfoundly reduced vital capacity in second decadeVentilatory dependency in second decadeRespiratory involvement in subset of patientsVentilator dependency in severe patients
Muscle sizeCalf hypertrophyCalf hypertrophy
MusculoskeletalContractures: ankles, hips, and kneesScoliosis: onset after loss of ambulationContractures: ankles and others in adulthood
CNSReduced cognitive ability or reduced verbal abilitySome patients have reduced cognitive ability
Muscle pathologyEndomysial fibrosis and fatty infiltrationVariable fiber size and myopathic groupingFiber degeneration/regenerationDystrophin:absentSarcoglycans: secondary reductionVariable fiber sizeEndomysial connective tissue and fatty infiltrationFiber degenerationFiber regenerationDystrophin: reduced (usually 10-60% of normal)
Blood chemistry and hematologyCK: very high (10,000-50,000)High AST and ALT (normal GGT)High aldolaseCK: 5,000-20,000Lower levels with increasing age